Status:
UNKNOWN
Agonist Versus Classical HCG Trigger (Poor Responders, Normoresponders and High Responders)
Lead Sponsor:
Ginegorama S.L.
Conditions:
Ovulation Induction
In Vitro Fertilization (IVF)
Eligibility:
FEMALE
18-48 years
Phase:
NA
Brief Summary
Agonist triggering in controlled ovarian stimulation protocols is being used during last years (among high responder patients to avoid OHSS). Indeed, agonist triggering is more physiologic than HCG t...
Detailed Description
During the last years, ovulation triggering in controlled ovarian stimulation protocols has been used specially to avoid hyperstimulation syndromes (OHSS). Indeed, the substitution of the classical HC...
Eligibility Criteria
Inclusion
- Women scheduled for IVF treatment.
- First ovarian stimulation
- Two ovaries present
- No previous ovarian surgery
- No contraindication for any of the assigned treatments
Exclusion
- Previous ovarian surgery.
- Previous IVF treatments.
- Absence of one ovary
- Presence of an endometrioma
Key Trial Info
Start Date :
December 18 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2018
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03307720
Start Date
December 18 2017
End Date
May 1 2018
Last Update
December 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Reproduccion Bilbao Assisted Reproduction Center
Bilbao, Bizkaia, Spain, 48014